2025-04-22 - Analysis Report
## Sempra (SRE) Stock Analysis Report

**Summary of Key Figures:**

* **Cumulative Return (SRE):** 21.59%
* **Cumulative Return (VOO):** 72.42%
* **Return Difference (SRE vs VOO):** -50.8%
* **Relative Divergence:** 25.3% (Indicates SRE's performance is in the lower 25.3% percentile relative to its historical performance compared to VOO)
* **Current Price:** $70.46
* **5-Day Moving Average:** $70.38
* **20-Day Moving Average:** $69.26
* **60-Day Moving Average:** $74.13
* **RSI:** 47.84
* **PPO:** 0.85
* **Market Risk Indicator (MRI):** 0.41 (Medium Risk)
* **Expected Return (Long-Term):** -64.3% (vs S&P 500)


**1. Company Overview and Performance Comparison:**

Sempra is an energy infrastructure company.  The provided data shows that SRE significantly underperformed the S&P 500 (VOO) over the analyzed period, with a cumulative return of 21.59% compared to VOO's 72.42%. This represents a considerable difference of -50.8%.  The relative divergence of 25.3% suggests that this underperformance is relatively low compared to its historical performance relative to the S&P 500, though it is still significantly below market performance.

**2. Alpha and Beta Analysis:**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 13.0% | 68.0% | -20.0% | 0.0 | 27.9 |
| 2016-2018  | 17.0% | 71.0% | -4.0% | 0.4 | 29.1 |
| 2017-2019  | 45.0% | 71.0% | 11.0% | 0.3 | 41.9 |
| 2018-2020  | 12.0% | 71.0% | -18.0% | 1.6 | 36.6 |
| 2019-2021  | 15.0% | 57.0% | -45.0% | 2.0 | 39.3 |
| 2020-2022  | 2.0% | 68.1% | -7.0% | 2.1 | 47.3 |
| 2021-2023  | 29.0% | 69.8% | 9.0% | 0.7 | 47.2 |
| 2022-2024  | 17.0% | 69.8% | 0.4 | 0.4 | 57.2 |
| 2023-2025  | -38.0% | 69.8% | 1.4 | 1.4 | 46.4 |

The alpha values fluctuate significantly, indicating inconsistent outperformance relative to the market.  Beta values also vary, suggesting changes in the stock's volatility relative to the market. The large negative alpha in some years indicates substantial underperformance.


**3. Recent Price Movement and Indicators:**

The current price ($70.46) is slightly below the 5-day moving average ($70.38) and significantly below the 60-day moving average ($74.13), suggesting a possible short-term downward trend.  The price is above the 20-day moving average, indicating some short-term support. The recent price change (-$0.93) is a minor decline.  The RSI (47.84) is near the neutral level (50), while the PPO (0.86) suggests some positive momentum. The recent relative divergence shows short-term upward momentum.  The MRI (0.41) indicates a medium risk level.

**4. Recent Earnings Analysis:**

| 날짜       | EPS  | 매출       |
|------------|------|------------|
| 2024-11-06 | 1.01 | 2.57 B$     |
| 2024-08-06 | 1.13 | 2.48 B$     |
| 2024-05-07 | 1.27 | 3.70 B$     |
| 2023-11-03 | 1.14 | 2.89 B$     |
| 2024-11-06 | 1.14 | 2.89 B$     |

There's a duplicate entry for 2024-11-06. EPS and revenue show some volatility, with a notable drop in EPS in the most recent quarter.  Further investigation is needed to understand the reasons behind this fluctuation.

**5. Financial Information:**

**Revenue and Profitability:**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2024-12-31 | $3.76B | 49.23% |
| 2024-09-30 | $2.78B | 44.49% |
| 2024-06-30 | $3.01B | 44.20% |
| 2024-03-31 | $3.64B | 46.04% |
| 2023-12-31 | $3.49B | 40.79% |

Revenue shows some fluctuations but generally maintains a relatively high level. Profit margins are also relatively strong and appear to be improving.


**Capital and Profitability:**

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2024-12-31 | $31.24B | 2.16% |
| 2024-09-30 | $29.72B | 2.18% |
| 2024-06-30 | $29.50B | 2.46% |
| 2024-03-31 | $29.16B | 2.79% |
| 2023-12-31 | $28.70B | 2.61% |

Equity is steadily increasing, indicating strong financial health. ROE shows some fluctuation but remains generally positive.


**6. Overall Conclusion:**

SRE has significantly underperformed the S&P 500 over the analyzed period. While the recent price movement suggests some short-term stability,  the negative long-term expected return (-64.3% vs. S&P 500) and volatile earnings data raise concerns.  The company's financial health appears reasonably strong, based on its equity and profit margins.  However, the inconsistent performance and the significant underperformance relative to the market suggest a need for further in-depth analysis before making any investment decisions.  The large negative Alpha values suggest the need for further investigation into the underperformance against market benchmarks.  A thorough evaluation of the reasons behind the fluctuating EPS and revenue, alongside a deeper dive into the company's growth prospects, is crucial before any investment decision.
